Aptorum Group Limited (NASDAQ:APM) Sees Significant Increase in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 184,800 shares, a growth of 1,564.9% from the December 31st total of 11,100 shares. Currently, 4.7% of the shares of the stock are sold short. Based on an average daily volume of 2,190,000 shares, the days-to-cover ratio is presently 0.1 days.

Aptorum Group Trading Up 1.8 %

NASDAQ APM opened at $1.12 on Thursday. Aptorum Group has a 1 year low of $0.46 and a 1 year high of $17.49. The company’s 50 day simple moving average is $1.09 and its two-hundred day simple moving average is $1.94.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.